ERBB2 and neoplasm: A decrease in tumor uptake was observed for the dimeric form of another clone of the anti-HER2 affibody molecule, ZHER2:477, which was labeled using [64Cu]-DOTA (Figure 5B) [72] and [18F]-FBO [46].